Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001857044-24-000002
Filing Date
2024-10-04
Accepted
2024-10-04 17:21:50
Documents
1
Effectiveness Date
2024-10-04
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 14885
  Complete submission text file 0001857044-24-000002.txt   16172
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

EIN.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-522181 | Film No.: 241355689
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)